Imerys SA

  • Market Cap: N/A
  • Industry: Building Products
  • ISIN: FR0000120859
EUR
24.06
-0.14 (-0.58%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Imerys SA stock-summary
stock-summary
Imerys SA
Building Products
Imerys SA is a France-based specialty minerals company that provides a range of customizable solutions to many industries, such as construction materials, mobile energy, steelmaking, agri-food, automotive and cosmetics. The Company operates through two segments: Performance Minerals and High Temperature Materials and Solutions. Performance Minerals provides additives for paints and coatings, components for technical and conventional ceramics, additives for plastics and polymers, fillers and coatings for printing and writing paper, as well as board and packaging, filtration agents for liquid foodstuffs and blood plasma, specialty graphite for mobile energy and precision. High Temperature Materials and Solutions offers refractory minerals and solutions for high-temperature industrial processes, bentonite for foundry molds, corundum powders for abrasives and high-performance binders for floor screeds. The Company is active globally.
Company Coordinates stock-summary
Company Details
43 quai de Grenelle , PARIS None : 75015
stock-summary
Tel: 33 1 4955630033 1 49556655
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Patrick Kron
Chairman of the Board
Mr. Paul Desmarais
Vice Chairman of the Board
Mrs. Eliane Augelet-Petit
Employee Representative Director
Mr. Enrico d'Ortona
Employee Representative Director
Mr. Ian Gallienne
Director
Dhr. Colin Hall
Director
Mr. Ulysses Kiriacopoulos
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
984 Million
(Quarterly Results - Sep 2012)
Net Profit:
79 Million
stock-summary
Industry

Building Products

stock-summary
Market cap

EUR 1,976 Million ()

stock-summary
P/E

12.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

6.23%

stock-summary
Debt Equity

0.42

stock-summary
Return on Equity

5.15%

stock-summary
Price to Book

0.64